| Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities L Garofano, S Migliozzi, YT Oh, F D’Angelo, RD Najac, A Ko, B Frangaj, ... Nature Cancer 2 (2), 141-156, 2021 | 193 | 2021 |
| Single-cell characterization of macrophages in glioblastoma reveals MARCO as a mesenchymal pro-tumor marker AX Chen, RD Gartrell, J Zhao, PS Upadhyayula, W Zhao, J Yuan, ... Genome medicine 13 (1), 88, 2021 | 63 | 2021 |
| Deconvolution of cell type-specific drug responses in human tumor tissue with single-cell RNA-seq W Zhao, A Dovas, EF Spinazzi, HM Levitin, MA Banu, P Upadhyayula, ... Genome medicine 13 (1), 82, 2021 | 57 | 2021 |
| ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma VA Arrieta, AX Chen, JR Kane, SJ Kang, C Kassab, C Dmello, J Zhao, ... Nature cancer 2 (12), 1372-1386, 2021 | 49 | 2021 |
| Quantitatively predictable control of cellular protein levels through proteasomal degradation W Zhao, L Pferdehirt, L Segatori ACS Synthetic Biology 7 (2), 540-552, 2018 | 33 | 2018 |
| Sensitive detection of proteasomal activation using the Deg-On mammalian synthetic gene circuit W Zhao, M Bonem, C McWhite, JJ Silberg, L Segatori Nature Communications 5 (1), 3612, 2014 | 32 | 2014 |
| Chronic convection-enhanced delivery of topotecan for patients with recurrent glioblastoma: a first-in-patient, single-centre, single-arm, phase 1b trial EF Spinazzi, MG Argenziano, PS Upadhyayula, MA Banu, JA Neira, ... The Lancet Oncology 23 (11), 1409-1418, 2022 | 25 | 2022 |
| Input-dependent post-translational control of the reporter output enhances dynamic resolution of mammalian signaling systems BEK Jayanthi, W Zhao, L Segatori Methods in enzymology 622, 1-27, 2019 | 8 | 2019 |
| Single-cell based elucidation of molecularly-distinct glioblastoma states and drug sensitivity H Ding, DM Burgenske, W Zhao, PS Subramaniam, KK Bakken, L He, ... bioRxiv, 675439, 2019 | 6 | 2019 |
| Single-cell characterization of macrophages in glioblastoma reveals MARCO as a mesenchymal pro-tumor marker. Genome Med. 13, 88–13 AX Chen, RD Gartrell, J Zhao, PS Upadhyayula, W Zhao, J Yuan, ... | 5 | 2021 |
| Hysteretic genetic circuit for detection of proteasomal degradation in mammalian cells Y Zeng, B Bhagyashree, W Zhao, T Nguyen, L Segatori ACS Synthetic Biology 8 (9), 2025-2035, 2019 | 3 | 2019 |
| Treatment of Recurrent Glioblastoma by Chronic Convection-Enhanced Delivery of Topotecan EF Spinazzi, MG Argenziano, PS Upadhyayula, MA Banu, JA Neira, ... medRxiv, 2021.12. 04.21266935, 2021 | 2 | 2021 |
| TAMI-57. INDUCTION OF FERROPTOSIS PROMOTES IMMUNOGENIC CELL DEATH AND ACTIVATION OF THE IMMUNE MICROENVIRONMENT IN GLIOMA M Argenziano, M Banu, A Dovas, W Zhao, J Furnari, D Higgins, ... Neuro-Oncology 23 (Supplement_6), vi210-vi210, 2021 | 2 | 2021 |
| A cell state specific metabolic vulnerability to GPX4-dependent ferroptosis in glioblastoma MA Banu, A Dovas, MG Argenziano, W Zhao, HC Grajal, DMO Higgins, ... bioRxiv, 2023 | 1 | 2023 |
| Consensus scHPF Identifies Cell Type-Specific Drug Responses in Glioma by Integrating Large-Scale scRNA-seq HM Levitin, W Zhao, JN Bruce, P Canoll, PA Sims bioRxiv, 2023.12. 05.570193, 2023 | 1 | 2023 |
| Multiplexed single-cell lineage tracing of mitotic kinesin inhibitor resistance in glioblastoma YL Cheng, MA Banu, W Zhao, SS Rosenfeld, P Canoll, PA Sims Cell Reports 43 (5), 2024 | | 2024 |
| Microanatomy of Intracranial Human Thrombi by Single Nuclei Transcriptomics EF Spinazzi, VP Leifer, MG Argenziano, W Zhao, JE Alexander, ... Stroke 55 (Suppl_1), A102-A102, 2024 | | 2024 |
| FERROPTOSIS INDUCES IMMUNOGENIC CELL DEATH AND SYNERGIZES WITH CD47 BLOCKADE TO REPROGRAM THE GLIOMA MICROENVIRONMENT C Sperring, M Argenziano, M Banu, A Dovas, A Mela, W Zhao, J Furnari, ... NEURO-ONCOLOGY 25, 2023 | | 2023 |
| A lymph node slice culture model to characterize T cell activation dynamics and anti-viral responses in human tissue A George, J Davis-Porada, S Weng, W Zhao, DL Farber, P Sims The Journal of Immunology 210 (1_Supplement), 250.11-250.11, 2023 | | 2023 |
| ERK1/2 Phosphorylation Predicts Survival Following anti-pd-1 Immunotherapy in Recurrent Glioblastoma VAA Gonzalez, C Amidei, U Basu, D Brat, J Bruce, K Burdett, J Burks, ... JOURNAL OF NEUROSURGERY 136 (5), 2022 | | 2022 |
